EXHIBIT 10.9 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the first day of April, 2000, by and between John F. DeBernardis ("Employee"), and MOLECULAR GERIATRICS CORPORATION, a Delaware corporation having its...Employment Agreement • March 31st, 2003 • Hemoxymed Inc • Biological products, (no disgnostic substances) • Illinois
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement") is made and entered into as of this ___ day of __________, 2004, by and among Applied NeuroSolutions, Inc., a Delaware corporation (the "Company"), and the investors...Registration Rights Agreement • February 13th, 2004 • Hemoxymed Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the first day of November, 2004, by and between Daniel J. Kerkman ("Employee"), and APPLIED NEUROSOLUTIONS, INC. ("APNS"), a Delaware corporation...Employment Agreement • March 25th, 2005 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
RECITALSConsulting Agreement • March 31st, 2003 • Hemoxymed Inc • Biological products, (no disgnostic substances) • New York
RECITALSPurchase Agreement • February 13th, 2004 • Hemoxymed Inc • Biological products, (no disgnostic substances) • New York
ANDWarrant Agreement • March 19th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • New York
Exhibit 10.2 This Warrant has not been registered under the Securities Act of 1993, as amended, or any applicable state securities laws, and may not be sold or transferred unless such sale or transfer is in accordance with the registration...Common Stock Purchase Warrant • December 17th, 2004 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
1 EXHIBIT 10.6 AGREEMENTEmployment Agreement • August 8th, 1997 • Ophidian Pharmaceuticals Inc
ITEM 6 - #10.11 LEASELease • August 5th, 1999 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • Wisconsin
JOINT FILING AGREEMENTJoint Filing Agreement • September 30th, 2002 • Hemoxymed Inc • Biological products, (no disgnostic substances)
This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
1,600,000 UNITS, EACH UNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE REDEEMABLE WARRANT OPHIDIAN PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 19th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • New York
BY AND AMONGMerger Agreement • September 23rd, 2002 • Hemoxymed Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.8 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the first day of April, 2000, by and between Bruce N. Barron ("Employee"), and MOLECULAR GERIATRICS CORPORATION, a Delaware corporation having its...Employment Agreement • March 31st, 2003 • Hemoxymed Inc • Biological products, (no disgnostic substances) • Illinois
Exhibit A to Ophidian Pharmaceuticals, Inc. Proxy StatementAsset Purchase Agreement • October 10th, 2000 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • Wisconsin
CONFIDENTIAL PORTIONS OF THIS AGREEMENT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT.License Agreement • March 25th, 2005 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
R E C I T A L S:Purchase Agreement • March 11th, 1999 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • Illinois
EXHIBIT 1.1 [Form of Underwriting Agreement - Subject to Additional Review] 2,500,000 SHARES OF COMMON STOCK AND 2,500,000 REDEEMABLE WARRANTS OPHIDIAN PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 8th, 1997 • Ophidian Pharmaceuticals Inc • New York
AGREEMENTEmployment Agreement • January 27th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research
ANDWarrant Agreement • January 29th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • New York
ANDRepresentatives' Warrant Agreement • March 19th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • New York
i) copies of an executed Unit Purchase Agreement;Unit Purchase Agreement • February 13th, 2004 • Hemoxymed Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBT 10.10 LEASE AGREEMENT TABLE OF CONTENTSLease Agreement • March 31st, 2003 • Hemoxymed Inc • Biological products, (no disgnostic substances)
AGREEMENTEmployment Agreement • December 24th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • Wisconsin
Exhibit 10.12 Agreement between Hemox/EC Page 1 June 20, 2003 Mr. Bruce N. Barron, CEO Hemoxymed, Inc. 50 Lakeview Pkwy, Suite 111 Vernon Hills, IL 60061 Dear Bruce: This letter will confirm the following agreement and understanding between Hemoxymed,...Financial Public Relations Agreement • March 19th, 2004 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances)
STATEMENT -----------License and Collaborative Research Agreement • March 31st, 2003 • Hemoxymed Inc • Biological products, (no disgnostic substances)
AGREEMENT BETWEENAgreement • February 17th, 1998 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research • Indiana
PURCHASE AGREEMENTPurchase Agreement • November 14th, 2007 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • New York
THIS PURCHASE AGREEMENT (“Agreement”) is made as of the 28th day of September 2007 by and among Applied NeuroSolutions, Inc., a Delaware corporation (the “Company”), and SF Capital Partners Ltd., a British Virgin Islands corporation (the “Investor”).
AGREEMENTEmployment Agreement • November 10th, 1997 • Ophidian Pharmaceuticals Inc • Services-commercial physical & biological research
HEMOXYMED, INC. COMMON STOCK WARRANT AGREEMENTCommon Stock Warrant Agreement • December 17th, 2004 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGER BY AND AMONG OPHIDIAN PHARMACEUTICALS, INC., OPHIDIAN HOLDINGS, INC. And HEMOXYMED, INC. Dated as of April 16, 2001Merger Agreement • August 8th, 2001 • Ophidian Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGER dated as of April 16, 2001 (the "Agreement"), by and among OPHIDIAN PHARMACEUTICALS, INC., a Delaware corporation ("ACQUIROR"), OPHIDIAN HOLDINGS, INC., a Delaware corporation and wholly-owned subsidiary of ACQUIROR ("Sub"), and HEMOXYMED, INC., a California corporation ("TARGET") (Sub and TARGET being hereinafter collectively referred to as the "Constituent Corporations").
FIFTH AMENDMENT AGREEMENT<?xml:namespace prefix = o ns = "urn:schemas- microsoft-com:office:office" />Fifth Amendment Agreement • March 24th, 2010 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances)
This Fifth Amendment Agreement is made effective November ___, 2009 by and between Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University, a corporation organized and existing under the laws of the State of New York, having an office and place of business at 1300 Morris Park Avenue, Bronx, New York 10461 ("AECOM") and Applied NeuroSolutions, Inc. (formerly known as Molecular Geriatrics Corp.), a corporation organized and existing under the laws of the State of Delaware, having an office and place of business at 50 Lakeview Parkway, Suite 111, Vernon Hills, Illinois 60061 ("Licensee").
EMPLOYMENT AGREEMENTEmployment Agreement • March 20th, 2008 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
This Employment Agreement (the “Agreement”) is entered into on this 17th day of March 2008 and is effective as of August 29, 2006 (the “Effective Date”), by and between Ellen R. Hoffing (the “Executive”) and Applied NeuroSolutions, Inc. (the “Company”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2011 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on this Amendment No. 2 to Schedule 13G (including amendments thereto) with respect to certain shares of Common Stock of Applied Neurosolutions Inc. and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 14th, 2007 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this 28th day of September, 2007, by and among Applied NeuroSolutions, Inc., a Delaware corporation (the “Company”), and SF Capital Partners Ltd., a British Virgin Islands corporation (the “Investor”).
CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • January 7th, 2009 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • New York
This Convertible Note Purchase Agreement (this "Agreement") is made as of December __, 2008 between Applied NeuroSolutions, Inc., a Delaware corporation (the "Company"), and each of the purchasers listed on Schedule I hereto (each a “Purchaser” and, collectively, the "Purchasers").
